Nonpharmaceutical Interventions for Pandemic Influenza, International Measures
Top Cited Papers
Open Access
- 1 January 2006
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 12 (1) , 81-87
- https://doi.org/10.3201/eid1201.051370
Abstract
Since global availability of vaccine and antiviral agents against influenza caused by novel human subtypes is insufficient, the World Health Organization (WHO) recommends nonpharmaceutical public health interventions to contain infection, delay spread, and reduce the impact of pandemic disease. Virus transmission characteristics will not be completely known in advance, but difficulties in influenza control typically include peak infectivity early in illness, a short interval between cases, and to a lesser extent, transmission from persons with incubating or asymptomatic infection. Screening and quarantining entering travelers at international borders did not substantially delay virus introduction in past pandemics, except in some island countries, and will likely be even less effective in the modern era. Instead, WHO recommends providing information to international travelers and possibly screening travelers departing countries with transmissible human infection. The principal focus of interventions against pandemic influenza spread should be at national and community levels rather than international borders.Keywords
This publication has 36 references indexed in Scilit:
- Nonpharmaceutical Interventions for Pandemic Influenza, National and Community MeasuresEmerging Infectious Diseases, 2012
- Nonpharmaceutical Interventions for Pandemic Influenza, International MeasuresEmerging Infectious Diseases, 2006
- Strategies for containing an emerging influenza pandemic in Southeast AsiaNature, 2005
- Transmissibility of 1918 pandemic influenzaNature, 2004
- Cruise Ships: High-Risk Passengers and the Global Spread of New Influenza VirusesClinical Infectious Diseases, 2000
- Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.Journal of Clinical Investigation, 1998
- Survival of Influenza Viruses on Environmental SurfacesThe Journal of Infectious Diseases, 1982
- Patterns of Shedding of Myxoviruses and Paramyxoviruses in ChildrenThe Journal of Infectious Diseases, 1981
- Correlated Studies of a Recombinant Influenza-Virus Vaccine. III. Protection against Experimental Influenza in ManThe Journal of Infectious Diseases, 1971
- Proved viraemia in asian influenza (Hong Kong variant) during incubation periodBMJ, 1969